Amerisourcebergen Corp ABC:NYSE

Last Price$96.11Cboe Real-Time Last Sale as of 1:47PM ET 9/25/20
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+1.45(1.53%)
Bid (Size)$96.08 (102)
Ask (Size)$96.24 (54)
Day Low / High$94.20 - 96.33
Volume426.2 K

View Medical Distributors IndustryPeer Comparison as of 09/25/2020


Amerisourcebergen Corp ( NYSE )

Price: $96.11
Change: +1.45 (1.53%)
Volume: 426.2 K
1:47PM ET 9/25/2020

Mckesson Corp ( NYSE )

Price: $148.24
Change: +1.68 (1.15%)
Volume: 445.9 K
1:48PM ET 9/25/2020

Cardinal Health Inc ( NYSE )

Price: $47.22
Change: +1.41 (3.08%)
Volume: 1.5 M
1:50PM ET 9/25/2020

Henry Schein Inc ( NASDAQ )

Price: $58.39
Change: +0.11 (0.19%)
Volume: 328.0 K
1:50PM ET 9/25/2020

Patterson Companies Inc ( NASDAQ )

Price: $23.21
Change: +0.09 (0.39%)
Volume: 270.2 K
1:50PM ET 9/25/2020

Read more news Recent News

AmerisourceBergen's Board Reportedly to Face Lawsuit Claiming It Allowed Unit to Illegally Sell Cancer Drug Syringes
11:57AM ET 8/25/2020 MT Newswires

AmerisourceBergen's (ABC) board will face a derivative lawsuit claiming that it allowed its unit, Oncology Supply Pharmacy Services, to sell unsterile...

Market Chatter: US States Demand $26.4 Billion in Settlement From Pharma Companies in Opioid Lawsuit
3:41PM ET 8/18/2020 MT Newswires

US states are seeking $26.4 billion from pharmaceutical companies including McKesson (MCK), AmerisourceBergen (ABC), Cardinal Health (CAH) and Johnson &...

AmerisourceBergen's Q4, 2020 and 2021 Earnings Estimates Raised
11:15PM ET 8/10/2020 MT Newswires

Q4, 2020, and 2021`s consensus estimates for AmerisourceBergen Inc (NYSE:ABC, Recent Price: 103.04) have been revised upward. The Q4 earnings estimate has...

--Analyst Actions: UBS Lifts AmerisourceBergen PT to $112 From $99, Maintains Buy Rating
1:13PM ET 8/10/2020 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Company Profile

Business DescriptionAmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company was founded in 1947 and is headquartered in Chesterbrook, PA. View company web site for more details
Address1300 Morris Drive
Chesterbrook, Pennsylvania 19087-5594
Number of Employees21,000
Recent SEC Filing09/16/20204
Chairman, President & Chief Executive OfficerSteven H. Collis
Chief Financial Officer & Executive Vice PresidentJames Francis Cleary
Chief Information Officer & Executive VPDale B. Danilewitz
Chief Compliance Officer & Executive OfficerKathy Habecker Gaddes

Company Highlights

Price Open$94.20
Previous Close$94.66
52 Week Range$72.06 - 106.45
Market Capitalization$19.6 B
Shares Outstanding204.1 M
SectorDistribution Services
IndustryMedical Distributors
Current Dividend / Yield$0.42 / 1.77%
Dividend Ex-Date08/14/2020
Dividend Pay-Date09/01/2020
Dividend Yield 5 Year Average1.65%
Next Earnings Announcement11/05/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / Earnings12.64
Earnings per Share$9.98
Beta vs. S&P 500N/A
Revenue$167.9 B
Net Profit Margin0.84%
Return on Equity47.28%

Analyst Ratings as of 09/01/2020

Consensus RecommendationConsensus Icon
Powered by Factset